Ongoing elimination efforts have altered the global distribution of Onchocerca volvulus, the agent of river blindness, and further population restructuring is expected as efforts continue.

The Food and Drug Administration (FDA) has approved moxidectin for the treatment of onchocerciasis (river blindness) due to Onchocerca volvulus in patients ≥12 years of age.. Moxidectin, a ...

Recent reports of patients failing to respond to ivermectin, the standard drug for treating river blindness (onchocerciasis), have suggested the emergence of drug-resistant Onchocerca volvulus ...

In sub-Saharan Africa and parts of Latin America, there is a parasitic worm that infects about 25m people, causing serious skin diseases, epilepsy and blindness. Known as Onchocerca volvulus, it ...

Onchocerca volvulus -- the parasite that causes river blindness--has not been shown to affect brain function, which would be required if the parasite were also directly responsible for causing NS.

Looking at the genome of worm Onchocerca volvulus may help scientists find new drugs to kill the parasite. By Léa Surugue Published 21 November 2016, 5:44 PM GMT.

Onchocerciasis is an infectious disease that can cause blindness and permanent skin damage. The source of onchocerciasis is a parasitic worm called Onchocerca volvulus. A person can contract this ...

The World Health Organization (WHO) congratulates Niger for having met the criteria for onchocerciasis elimination, making it the fifth country globally and the first country in Africa to be ...

A lead researcher into the mysterious Nodding Syndrome at the Ministry of Health has defined Onchocerca Volvulus (OV) as a parasite responsible for the cause of nodding in children where several ...